Beta Bionics, Inc.
BBNX
$17.50
$0.462.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 41.13% | -58.25% | -- | ||
| Total Depreciation and Amortization | 8.11% | 14.18% | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -71.68% | 122.36% | -- | ||
| Change in Net Operating Assets | 76.84% | -99.57% | -- | ||
| Cash from Operations | 31.94% | -39.89% | -- | ||
| Capital Expenditure | -434.23% | 40.64% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 104.45% | -514.37% | -- | ||
| Cash from Investing | 103.45% | -503.88% | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -99.98% | 555,476.32% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -99.98% | 271.09% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -161.38% | -7.17% | -- | ||